Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990)
HKEX:6990
Holding HK:6990?
Track your performance easily
6990 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$63.65 - HK$223.80
Previous CloseHK$172.1
Volume683.93K
Average Volume (3M)468.81K
Market Cap
HK$35.30B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 19, 2024EPS Estimate
-HK$1.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.15
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume468,808
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$240.00Price Target Upside39.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H News
PremiumCompany Announcements
Sichuan Kelun-Biotech Gains Approval for SKB571 Trials
PremiumCompany Announcements
Sichuan Kelun-Biotech’s SKB535 Gains Crucial Drug Approval
PremiumCompany Announcements
Sichuan Kelun-Biotech Partners with China Resources KelunPremiumCompany Announcements
Sichuan Kelun-Biotech Plans Amendments to Corporate Structure
PremiumCompany Announcements
Sichuan Kelun-Biotech’s Promising Drug Gains Key Approval
PremiumCompany Announcements
Sichuan Kelun-Biotech Expands Portfolio with Major Deposit
PremiumCompany Announcements
Sichuan Kelun-Biotech Completes H Share Circulation
PremiumCompany Announcements
Kelun-Biotech Reports Promising Cancer Drug ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.49% Mutual Funds
― Other Institutional Investors
98.63% Public Companies and
Individual Investors
6990 FAQ
What was Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s price range in the past 12 months?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H lowest stock price was HK$63.65 and its highest was HK$223.80 in the past 12 months.
What is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s market cap?
Currently, no data Available
When is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s upcoming earnings report date?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s upcoming earnings report date is Aug 19, 2024 which is 95 days ago.
How were Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s earnings last quarter?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H released its earnings results on Mar 25, 2024. The company reported -HK$2.658 earnings per share for the quarter, missing the consensus estimate of -HK$1.468 by -HK$1.19.
Is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H overvalued?
According to Wall Street analysts Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s price is currently Undervalued.
Does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H pay dividends?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H does not currently pay dividends.
What is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s EPS estimate?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s EPS estimate is -HK$1.16.
How many shares outstanding does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H have?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has 131,430,790 shares outstanding.
What happened to Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s price movement after its last earnings report?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H reported an EPS of -HK$2.658 in its last earnings report, missing expectations of -HK$1.468. Following the earnings report the stock price went up 5.217%.
Which hedge fund is a major shareholder of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6990
---
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.64%
12-Months-Change
Fundamentals
Return on Equity
-17.38%
Trailing 12-Months
Asset Growth
49.10%
Trailing 12-Months
6990 Stock 12 Month Forecast
Average Price Target
HK$240.00
▲(39.45% Upside)
Technical Analysis
Best Analysts Covering 6990
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+13.20%
reiterated a buy rating 3 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +13.20% per trade.
---